Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-04-01 Sale | 2024-04-03 5:37 pm | Immuneering Corp | IMRX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner | 400,000 | $2.9005 | $1,160,181 | 2,895,273 (Indirect) | View |
2024-03-22 Purchase | 2024-03-25 4:03 pm | Immuneering Corp | IMRX | Schall Thomas J. Director | 2,900 | $2.5465 | $7,385 | 2,900 (Direct) | View |
2024-03-22 Purchase | 2024-03-25 09:13 am | Immuneering Corp | IMRX | Feinberg Peter Director | 25,000 | $2.5485 | $63,713 | 1,096,064 (Indirect Direct) | View |
2024-03-22 Purchase | 2024-03-25 09:10 am | Immuneering Corp | IMRX | Brakewood Harold Eugene Chief Business Officer | 3,900 | $2.568 | $10,015 | 3,900 (Direct) | View |
2024-03-21 Purchase | 2024-03-25 09:04 am | Immuneering Corp | IMRX | Morales Mallory Chief Accounting Officer | 1,500 | $2.6727 | $4,009 | 8,278 (Direct) | View |
2024-03-20 Purchase | 2024-03-21 09:11 am | Immuneering Corp | IMRX | Neufeld Leah R CHIEF PEOPLE OFFICER | 3,818 | $2.8793 | $10,993 | 10,029 (Direct) | View |
2024-03-20 Purchase | 2024-03-21 09:06 am | Immuneering Corp | IMRX | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | 7,000 | $2.86 | $20,020 | 345,896 (Direct) | View |
2024-03-18 Purchase | 2024-03-19 7:10 pm | Immuneering Corp | IMRX | BERMAN ANN E Director | 57,965 | $2.1295 | $123,436 | 67,465 (Direct) | View |
2024-03-18 Purchase | 2024-03-19 7:04 pm | Immuneering Corp | IMRX | Feinberg Peter Director | 75,000 | $2.4408 | $183,058 | 1,071,064 (Indirect Direct) | View |
2024-03-19 Purchase | 2024-03-19 6:59 pm | Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO 10% Owner | 20,000 | $2.7663 | $55,326 | 3,176,779 (Indirect Direct) | View |
2024-03-14 Sale | 2024-03-18 5:59 pm | Immuneering Corp | IMRX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner | 909,091 | $3.0239 | $2,749,003 | 3,295,273 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-15 Option Award | 2024-03-25 09:04 am | N/A N/A | Immuneering Corp | IMRX | Morales Mallory Chief Accounting Officer | 4,344 | $1.62 | 8,278 (Direct) | View |
2024-03-15 Option Award | 2024-03-21 09:11 am | N/A N/A | Immuneering Corp | IMRX | Neufeld Leah R CHIEF PEOPLE OFFICER | 6,211 | $1.62 | 10,029 (Direct) | View |
2024-03-15 Option Award | 2024-03-21 09:06 am | N/A N/A | Immuneering Corp | IMRX | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | 6,211 | $1.62 | 345,896 (Direct) | View |
2024-03-15 Option Award | 2024-03-19 7:14 pm | N/A N/A | Immuneering Corp | IMRX | Bookman Michael CHIEF LEGAL OFFICER, SECRETARY | 1,448 | $1.62 | 3,850 (Direct) | View |
2024-03-11 Option Award | 2024-03-12 5:02 pm | N/A 2034-03-11 | Immuneering Corp | IMRX | Schall Thomas J. Director | 35,000 | $0 | 35,000 (Direct) | View |
2024-02-08 Option Award | 2024-02-09 4:30 pm | N/A 2034-02-08 | Immuneering Corp | IMRX | Morales Mallory Chief Accounting Officer | 60,500 | $0 | 60,500 (Direct) | View |
2024-02-08 Option Award | 2024-02-09 4:26 pm | N/A 2034-02-08 | Immuneering Corp | IMRX | Neufeld Leah R CHIEF PEOPLE OFFICER | 60,500 | $0 | 60,500 (Direct) | View |
2024-02-08 Option Award | 2024-02-09 4:21 pm | N/A 2034-02-08 | Immuneering Corp | IMRX | Brakewood Harold Eugene Chief Business Officer | 60,500 | $0 | 60,500 (Direct) | View |
2024-02-08 Option Award | 2024-02-09 4:17 pm | N/A 2034-02-08 | Immuneering Corp | IMRX | Bookman Michael CHIEF LEGAL OFFICER, SECRETARY | 93,000 | $0 | 93,000 (Direct) | View |
2024-02-08 Option Award | 2024-02-09 4:12 pm | N/A 2034-02-08 | Immuneering Corp | IMRX | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | 130,900 | $0 | 130,900 (Direct) | View |
2024-02-08 Option Award | 2024-02-09 4:07 pm | N/A 2034-02-08 | Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO 10% Owner | 260,700 | $0 | 260,700 (Direct) | View |
2024-01-01 Option Award | 2024-01-02 4:31 pm | N/A 2034-01-01 | Immuneering Corp | IMRX | KEATING LAURIE Director | 6,879 | $0 | 6,879 (Direct) | View |
2024-01-01 Option Award | 2024-01-02 4:26 pm | N/A 2034-01-01 | Immuneering Corp | IMRX | Feinberg Peter Director | 6,879 | $0 | 6,879 (Direct) | View |
2023-06-14 Option Award | 2023-06-15 4:44 pm | N/A 2033-06-14 | Immuneering Corp | IMRX | KEATING LAURIE Director | 17,500 | $0 | 17,500 (Direct) | View |
2023-06-14 Option Award | 2023-06-15 4:39 pm | N/A 2033-06-14 | Immuneering Corp | IMRX | HAUSMAN DIANA Director | 17,500 | $0 | 17,500 (Direct) | View |
2023-06-14 Option Award | 2023-06-15 4:35 pm | N/A 2033-06-14 | Immuneering Corp | IMRX | Feinberg Peter Director | 17,500 | $0 | 17,500 (Direct) | View |
2023-06-14 Option Award | 2023-06-15 4:30 pm | N/A 2033-06-14 | Immuneering Corp | IMRX | CARPENTER ROBERT J Director | 17,500 | $0 | 17,500 (Direct) | View |
2023-06-14 Option Award | 2023-06-15 4:25 pm | N/A 2033-06-14 | Immuneering Corp | IMRX | BERMAN ANN E Director | 17,500 | $0 | 17,500 (Direct) | View |
2023-06-13 Option Award | 2023-06-14 4:15 pm | N/A 2033-06-13 | Immuneering Corp | IMRX | Morales Mallory VICE PRESIDENT, FINANCE | 15,000 | $0 | 15,000 (Direct) | View |
Ownership | 2023-04-24 5:21 pm | N/A N/A | Immuneering Corp | IMRX | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Chen Bihua 10% Owner | 0 | $0 | 4,204,364 (Indirect) | View |
2023-03-31 Option Award | 2023-04-03 4:54 pm | N/A 2033-03-31 | Immuneering Corp | IMRX | Brakewood Harold Eugene Chief Business Officer | 165,000 | $0 | 165,000 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 4:30 pm | N/A 2033-02-15 | Immuneering Corp | IMRX | Morales Mallory VICE PRESIDENT, FINANCE | 72,000 | $0 | 72,000 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 4:16 pm | N/A 2033-02-15 | Immuneering Corp | IMRX | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | 187,000 | $0 | 187,000 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 4:16 pm | N/A 2033-02-15 | Immuneering Corp | IMRX | Neufeld Leah R CHIEF PEOPLE OFFICER | 105,000 | $0 | 105,000 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 4:16 pm | N/A 2033-02-15 | Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO 10% Owner | 374,000 | $0 | 726,244 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 4:15 pm | N/A 2033-02-15 | Immuneering Corp | IMRX | Barrett Scott CHIEF MEDICAL OFFICER | 110,000 | $0 | 110,000 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 4:15 pm | N/A 2033-02-15 | Immuneering Corp | IMRX | Bookman Michael GENERAL COUNSEL AND SECRETARY | 143,000 | $0 | 143,000 (Direct) | View |
2022-12-22 Exercise | 2022-12-27 08:14 am | N/A 2029-12-15 | Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO 10% Owner | 2,500 | $0 | 3,360,279 (Direct) | View |
2022-12-22 Exercise | 2022-12-27 08:14 am | N/A N/A | Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO 10% Owner | 2,500 | $3.01 | 3,360,279 (Direct) | View |
2022-10-31 Option Award | 2022-11-02 09:03 am | N/A 2032-10-31 | Immuneering Corp | IMRX | Neufeld Leah R CHIEF PEOPLE OFFICER | 88,600 | $0 | 88,600 (Direct) | View |